Efek Samping Steroid Sistemik pada Terapi Pemvigus Vulgaris

Penulis

  • Felicia Aviana Fakultas Kedokteran, Universitas Hang Tuah, Surabaya, Jawa Timur, Indonesia
  • I Made Birawan SMF Ilmu Kesehatan Kulit dan Kelamin, RSUD Bali Mandara, Denpasar, Bali, Indonesia

DOI:

https://doi.org/10.55175/cdk.v48i9.117

Kata Kunci:

pemfigus vulgaris, autoimun, steroid

Abstrak

Pemfigus vulgaris (PV) adalah penyakit autoimun vesikobulosa pada kulit dan membran mukosa yang secara histologi ditandai bula intraepidermal yang disebabkan oleh akantolisis. Steroid sistemik merupakan terapi utama PV. Artikel ini membahas efek samping terapi steroid parenteral pada pemfigus vulgaris.

Pemphigus Vulgaris (PV) is an autoimmune blistering disease of skin and mucous membranes, histologically defined by intraepidermal blister due to acantholysis. Systemic steroid is the first-line treatment in PV. This article briefly discussedthe adverse effect of parenteral steroid in the treatment of pemphigus vulgaris.

Unduhan

Data unduhan belum tersedia.

Referensi

Rusli. Bahan ajar farmasi: Farmasi klinik. Edisi 2018. Jakarta: Kementrian Kesehatan RI; 2018. Available from: http://bppsdmk.kemkes.go.id/pusdiksdmk/wp-content/uploads/2018/09/Farmasi-Klinik_SC.pdf

Noviani N, Nurilawati V. Bahan ajar keperawatan gigi: Farmakologi. Edisi 2017. Jakarta: Kementrian Kesehatan Republik Indonesia; 2017. Available from: http://bppsdmk.kemkes.go.id/pusdiksdmk/wp-content/uploads/2017/11/Farmakologi_bab_1-3.pdf

Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allerg Asthma Clin Immunol. 2013;9(1):30.

Stanley J.R. Pemphigus. In: Wolff K, Goldsmith L, Katz S, Gilchrest B, Paller AS, Leffell D. Fitzpatrick's dermatology in general medicine. 7th ed. New York: McGraw-Hill; 2008 .p. 459.

Kridin K. Emerging treatment options for the management of pemphigus vulgaris. Therapeutics and clinical risk management. 2018;14:757.

Grennan D, Wang S. Steroid side effects. JAMA. 2019;322(3):282.

Gregoriou S, Efthymiou O, Stefanaki C, Rigopoulos D. Management of pemphigus vulgaris: Challenges and solutions. Clin Cosmetic Investig Dermatol. 2015;8:521.

Wiryadi BE. Chronic vesicobulous dermatosis. Menaldi SLSW. Dermatology and venereology. 7th ed. Jakarta. UI Publ. 2017. p. 234-8.

Joly P, Litrowski N. Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis). Clin Dermatol. 2011;29(4):432–6

Kilic A. Pemphigus: Subtypes, clinical features, diagnosis, and treatment. Autoimmune bullous diseases. Intech Open. 2017

Dowling JR, Anderson KL, Huang WW. Asboe-Hansen sign in toxic epidermal necrolysis. Cutis. 2019;103(4):6-8.

Setyawati NK, Sari AN, Mahariski PA. Glucocorticoid-induced hyperglycemia (GIH) in pemphigus vulgaris patient at Bangli District General Hospital: A case report.Bali Dermatol Venereol J (BDV). 2019;2(2):28-33

Porro AM, Hans Filho G, Santi CG. Consensus on the treatment of autoimmune bullous dermatoses: Pemphigus vulgaris and pemphigus foliaceus. Brazil Soc Dermatol. 2019;94(2):20-32.

Sethy PK, Khandpur S, Sharma VK. Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris. Indian J Dermatol Venereol Leprol. 2009;75(5):476.

Joly P, Horvath B, Patsatsi , Uzun S, Bech R, Beissert S, et al. Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2020;34(9):1900-13.

Yanovsky RL, McLeod M, Ahmed AR. Treatment of pemphigus vulgaris: Part 1–current therapies. Expert Rev Clin Immunol. 2019;15(10):1047-60.

Shahidi-Dadras M, Karami A, Toosy P, Shafiyan A. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris. Arch Iranian Med. 2007;10(1):1-6

Akhtar SJ, Hasan MU. Treatment of pemphigus: A local experience. JPMA. 1998;48(300).

Sakallioglu EE, Acikgoz G, Keles G, Senturk N, Karagoz F. Pemphigus vulgaris and complications of systemic corticosteroid therapy: A case report. J Oral Sci.2003;45(3):165-9.

Uddin MJ, Islam AM, Ali ME, Wahab MA, Khondker L, Khan MS. Safety of parenteral dexamethasone vs. oral prednisolone in the treatment of pemphigus vulgaris. J Pak Assoc Dermatol. 2016;23(2):163-7

Diterbitkan

2021-09-01

Cara Mengutip

Aviana, F., & Birawan, I. M. (2021). Efek Samping Steroid Sistemik pada Terapi Pemvigus Vulgaris. Cermin Dunia Kedokteran, 48(9), 330–334. https://doi.org/10.55175/cdk.v48i9.117

Terbitan

Bagian

Articles